bpc-157 anzctr BPC 157 BPC-157 Injectable Peptide for Healing
Description
Cancer Cell 25 (6), 719734
Document dosing rationales (route, concentration, frequency) and use pilot results to set dose escalation or fixeddose arms in the main study
It's frustrating, and it's avoidable
Informed Consent and Patient Education Informed consent discussions for BPC-157 use should clearly communicate the investigational nature of the peptide, lack of FDA approval, limited human safety and efficacy data, and the reliance on animal studies for much of the supporting evidence
